Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2016

  • ID: 3514216
  • Report
  • Region: Global
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The author announced the results of its Cystic Fibrosis patient population study in a new report ‘Global Cystic Fibrosis Epidemiology and Patient Flow Analysis - 2016’. The report provides insights into Cystic Fibrosis epidemiology, Cystic Fibrosis diagnosed patients, and Cystic Fibrosis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Cystic Fibrosis derived from epidemiological analysis, percentage of patients diagnosed with Cystic Fibrosis, and percentage of patients treated with Cystic Fibrosis therapy.

The study helps executives estimate Cystic Fibrosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Cystic Fibrosis prevalence, Cystic Fibrosis diagnosis rate, and Cystic Fibrosis treatment rate for the period 2015 - 2022. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.

Key Features of the Report:
- Cystic Fibrosis: Disease Definition
- Cystic Fibrosis Patient Flow
- Cystic Fibrosis Prevalence
- Cystic Fibrosis Diagnosed Patients
- Cystic Fibrosis Treated Patients

This report will take 1-2 business days to deliver.
Note: Product cover images may vary from those shown
2 of 3
1. Cystic Fibrosis: Disease Definition
2. Global Cystic Fibrosis Patient Flow
2A. Global Cystic Fibrosis Prevalence
2B. Global Cystic Fibrosis Diagnosed Patients
2C. Global Cystic Fibrosis Treated Patients
3. Cystic Fibrosis Patient Flow in the US
3A. Cystic Fibrosis Prevalence in the US
3B. Cystic Fibrosis Diagnosed Patients in the US
3C. Cystic Fibrosis Treated Patients in the US
4. Cystic Fibrosis Patient Flow in Europe
4A. Cystic Fibrosis Prevalence in Europe
4B. Cystic Fibrosis Diagnosed Patients in Europe
4C. Cystic Fibrosis Treated Patients in Europe
5. Cystic Fibrosis Patient Flow in Germany
5A. Cystic Fibrosis Prevalence in Germany
5B. Cystic Fibrosis Diagnosed Patients in Germany
5C. Cystic Fibrosis Treated Patients in Germany
6. Cystic Fibrosis Patient Flow in France
6A. Cystic Fibrosis Prevalence in France
6B. Cystic Fibrosis Diagnosed Patients in France
6C. Cystic Fibrosis Treated Patients in France
7. Cystic Fibrosis Patient Flow in Spain
7A. Cystic Fibrosis Prevalence in Spain
7B. Cystic Fibrosis Diagnosed Patients in Spain
7C. Cystic Fibrosis Treated Patients in Spain
8. Cystic Fibrosis Patient Flow in Italy
8A. Cystic Fibrosis Prevalence in Italy
8B. Cystic Fibrosis Diagnosed Patients in Italy
8C. Cystic Fibrosis Treated Patients in Italy
9. Cystic Fibrosis Patient Flow in UK
9A. Cystic Fibrosis Prevalence in UK
9B. Cystic Fibrosis Diagnosed Patients in UK
9C. Cystic Fibrosis Treated Patients in UK
10. Cystic Fibrosis Patient Flow in Japan
10A. Cystic Fibrosis Prevalence in Japan
10B. Cystic Fibrosis Diagnosed Patients in Japan
10C. Cystic Fibrosis Treated Patients in Japan
11. Appendix
12. Research Methodology
12A. Sources

Table 1: Global Cystic Fibrosis Patient Flow (2015)
Table 2: Global Cystic Fibrosis Patient Flow Forecast (2015 - 2022)
Table 3: Cystic Fibrosis Patient Flow in the US (2015)
Table 4: Cystic Fibrosis Patient Flow Forecast in the US (2015 - 2022)
Table 5: Cystic Fibrosis Patient Flow in Europe (2015)
Table 6: Cystic Fibrosis Patient Flow Forecast in Europe (2015 - 2022)
Table 7: Cystic Fibrosis Patient Flow in Germany (2015)
Table 8: Cystic Fibrosis Patient Flow Forecast in Germany (2015 - 2022)
Table 9: Cystic Fibrosis Patient Flow in France (2015)
Table 10: Cystic Fibrosis Patient Flow Forecast in France (2015 - 2022)
Table 11: Cystic Fibrosis Patient Flow in Spain (2015)
Table 12: Cystic Fibrosis Patient Flow Forecast in Spain (2015 - 2022)
Table 13: Cystic Fibrosis Patient Flow in Italy (2015)
Table 14: Cystic Fibrosis Patient Flow Forecast in Italy (2015 - 2022)
Table 15: Cystic Fibrosis Patient Flow in UK (2015)
Table 16: Cystic Fibrosis Patient Flow Forecast in UK (2015 - 2022)
Table 17: Cystic Fibrosis Patient Flow in Japan (2015)
Table 18: Cystic Fibrosis Patient Flow Forecast in Japan (2015 - 2022)

Figure 1: Global Cystic Fibrosis Patient Flow (2015)
Figure 2: Global Cystic Fibrosis Patient Flow Forecast (2015 - 2022)
Figure 3: Cystic Fibrosis Patient Flow in the US (2015)
Figure 4: Cystic Fibrosis Patient Flow Forecast in the US (2015 - 2022)
Figure 5: Cystic Fibrosis Patient Flow in Europe (2015)
Figure 6: Cystic Fibrosis Patient Flow Forecast in Europe (2015 - 2022)
Figure 7: Cystic Fibrosis Patient Flow in Germany (2015)
Figure 8: Cystic Fibrosis Patient Flow Forecast in Germany (2015 - 2022)
Figure 9: Cystic Fibrosis Patient Flow in France (2015)
Figure 10: Cystic Fibrosis Patient Flow Forecast in France (2015 - 2022)
Figure 11: Cystic Fibrosis Patient Flow in Spain (2015)
Figure 12: Cystic Fibrosis Patient Flow Forecast in Spain (2015 - 2022)
Figure 13: Cystic Fibrosis Patient Flow in Italy (2015)
Figure 14: Cystic Fibrosis Patient Flow Forecast in Italy (2015 - 2022)
Figure 15: Cystic Fibrosis Patient Flow in UK (2015)
Figure 16: Cystic Fibrosis Patient Flow Forecast in UK (2015 - 2022)
Figure 17: Cystic Fibrosis Patient Flow in Japan (2015)
Figure 18: Cystic Fibrosis Patient Flow Forecast in Japan (2015 - 2022)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll